Search Results
- < Prev
1 of 1
- Next >
News Releases
-
Apr 22, 2013, 02:00 ET
DSM and DecImmune Therapeutics Sign Agreement to Develop N2 Pathway Blocking Antibody
DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM (NYSE, Euronext: DSM KON), announced today that it has signed an agreement with venture capital funded DecImmune Therapeutics of Cambridge, Massachusetts, USA The agreement covers the initiation of...
More news about: DSM Pharmaceutical Products , DecImmune Therapeutics
-
Apr 22, 2013, 02:00 ET
DSM announces June opening of new cGMP biopharmaceutical manufacturing operation in Brisbane, Australia
The DSM facility was built with cooperation from the Queensland and Commonwealth Governments of Australia. Karen King, President of DSM Biologics, the biopharmaceutical manufacturing business of DSM Pharmaceutical Products, stated, "We are thrilled to announce the June opening of our new cGMP...
More news about: DSM Pharmaceutical Products , Royal DSM , BioPharmaceuticals Australia (BPA)
- < Prev
1 of 1
- Next >
Modify your Search
| Quickly search for PR Newswire releases by adding our plugin to your browser search |
